Meeder Asset Management Inc Pacific Biosciences Of California, Inc. Transaction History

Meeder Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$19.26 - $30.08 $1,174 - $1,834	-61 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$24.86 - $35.02 $56,059 - $78,970	-2,255 Reduced 97.37%	61 $1,000
Q2 2021 Aug 09, 2021	SELL	$22.3 - $36.02 $94,507 - $152,652	-4,238 Reduced 64.66%	2,316 $81,000
Q1 2021 Apr 28, 2021	BUY	$26.38 - $51.15 $172,894 - $335,237	6,554 New	6,554 $219,000

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.